Neighborhood disadvantage, insurance status, and molecular profiling of patients with acute myeloid leukemia
- 24 May 2023
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 131, 107326
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelBlood, 2017
- Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemiaBlood, 2016
- Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North CarolinaCancer, 2016
- Next Generation Sequencing in the Clinic: a Patterns of Care Study in a Retrospective Cohort of Subjects Referred to a Genetic Medicine Clinic for Suspected Lynch SyndromeJournal of Genetic Counseling, 2015
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trialThe Lancet Oncology, 2015
- Nonbiological factors affecting survival in younger patients with acute myeloid leukemiaCancer, 2015
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted DrugsJAMA, 2014
- Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center InitiativeClinical Cancer Research, 2012
- Cancer Survival in Kentucky and Health Insurance CoverageArchives of internal medicine (1960), 2003
- The Relation between Health Insurance Coverage and Clinical Outcomes among Women with Breast CancerNew England Journal of Medicine, 1993